BTI
BNR

Blue Trust Inc’s Burning Rock Biotech BNR Stock Holding History

Blue Trust Inc’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25
Closed -$161 – 2501
2024
Q3 		$161 Buy
+25
New +$138 ﹤0.01% 2868
2024
Q1 		– Sell
-66
Closed -$1K – 2232
2023
Q4 		$1K Buy
+66
New +$607 ﹤0.01% 2270

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
CL
CRCM LP San Francisco, California $141M AUM 153.09% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return

Blue Trust Inc's BNR Position: Q4 2024 in Review

Blue Trust Inc sold out of Burning Rock Biotech (BNR) in Q4 2024, closing a stake of 25 shares — an estimated $161 sold.

Blue Trust Inc first reported a position in BNR in Q4 2023 and held it in 2 quarters. The position peaked at $1K in Q4 2023. 21 funds tracked by Wall St. Rank hold BNR as of Q4 2024.

  • Blue Trust Inc reported no remaining Burning Rock Biotech position as of Q4 2024 after selling out during the quarter.
  • Blue Trust Inc sold 25 Burning Rock Biotech shares in Q4 2024, an estimated $161.
  • Blue Trust Inc first reported a position in Burning Rock Biotech in Q4 2023 and held it in 2 quarters.
  • Blue Trust Inc's Burning Rock Biotech position peaked at $1K in Q4 2023.
  • 21 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2024.

Based on Blue Trust Inc's 13F filing for Q4 2024, filed 22 Jan 2025.